CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
61 hedge funds and large institutions have $842M invested in CureVac in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 9 closing their positions.
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
137% more capital invested
Capital invested by funds: $355M → $842M (+$487M)
42% more funds holding
Funds holding: 43 → 61 (+18)
1.56% more ownership
Funds ownership: 4.27% → 5.83% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
41% less call options, than puts
Call options by funds: $44M | Put options by funds: $74.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$69.3M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.38M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5M |
| 4 |
PM
Parametrica Management
Wanchai,
Hong Kong
|
+$2.93M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$29M |
| 2 |
Millennium Management
New York
|
-$22.4M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$21.1M |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$10.3M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$9.39M |
CVAC Hedge Fund Activity: Q4 2020 in Review
61 of the 5,629 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q4 2020, worth a combined $842M — up 137% from $355M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CVAC positions and 9 closed out — a net gain of 18 holders — while 14 added to existing stakes and 18 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $69.3M. The largest seller was DekaBank Deutsche Girozentrale, cutting an estimated $29M.
- 61 institutional investors held CureVac (CVAC) as of Q4 2020, up from 43 in Q3 2020.
- Funds reported $842M of CureVac stock for Q4 2020, up 137% quarter-over-quarter.
- 27 funds opened new CureVac positions in Q4 2020 and 9 closed out, a net change of +18 holders.
- The largest CureVac buyer in Q4 2020 was Baillie Gifford & Co, an estimated $69.3M added.
- The largest CureVac seller in Q4 2020 was DekaBank Deutsche Girozentrale, an estimated $29M sold.
Based on aggregated 13F filings for Q4 2020.